Analytical Data
-
Gene name
RHD
- Application
-
Alternative Names
RHD；Blood group Rh(D) polypeptide
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7RU08
-
Expression Region
1-417aa
-
AA Sequence
MSSKYPRSVRRCLPLWALTLEAALILLFYFFTHYDASLEDQKGLVASYQVGQDLTVMAAIGLGFLTSSFRRHSWSSVAFNLFMLALGVQWAILLDGFLSQFPSGKVVITLFSIRLATMSALSVLISVDAVLGKVNLAQLVVMVLVEVTALGNLRMVISNIFNTDYHMNMMHIYVFAAYFGLSVAWCLPKPLPEGTEDKDQTATIPSLSAMLGALFLWMFWPSFNSALLRSPIERKNAVFNTYYAVAVSVVTAISGSSLAHPQGKISKTYVHSAVLAGGVAVGTSCHLIPSPWLAMVLGLVAGLISVGGAKYLPGCCNRVLGIPHSSIMGYNFSLLGLLGEIIYIVLLVLDTVGAGNGMIGFQVLLSIGELSLAIVIALTSGLLTGLLLNLKIWKAPHEAKYFDDQVFWKFPHLAVGF
-
Molecular Weight
51.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RHD (Rhomboid-like domain) recombinant proteins have garnered significant attention in the field of molecular biology due to their crucial roles in various biological processes, including cell signaling, membrane dynamics, and protein quality control. These proteins, which are part of the rhomboid family of intramembrane proteases, are characterized by their unique structure that enables them to catalyze the cleavage of membrane proteins without fully extracting them from the lipid bilayer. Research into RHD recombinant proteins has expanded our understanding of how they can regulate the activity and stability of other proteins, impacting important cellular pathways such as apoptosis, development, and immune responses. Advances in recombinant DNA technology have facilitated the production and characterization of these proteins, allowing scientists to investigate their structure-function relationships and develop potential therapeutic applications. As a result, RHD proteins are being explored for their roles in various diseases, including cancer and neurodegenerative disorders, highlighting the importance of this research in both basic science and clinical settings. This area of study is poised to contribute valuable insights into protein interaction networks and post-translational modifications, ultimately aiming to harness the potential of RHD proteins for innovative biomedical solutions.
